Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28517977 | 0.90 | TAAR1 (0.51) | TAAR1HTR1ADRD2HTR7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28523036 | 0.88 | TAAR1 (0.46) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28511085 | 0.85 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28511084 | 0.85 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL30733601 | 0.85 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL30733605 | 0.84 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL28522435 | 0.84 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL28513760 | 0.84 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL29140413 | 0.84 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL29140412 | 0.83 | TAAR1 (0.45) | TAAR1HTR1ADRD2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118406063-A | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118576586-A | Methods of treating neurological and psychiatric disorders | 住友制药美国公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118406063-A | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-117800984-A | Chiral resolution method for preparing Ulotaront and enantiomer thereof | 江苏海洋大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-112135827-B | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-112135827-A | Salts, crystalline forms and methods for preparing the same | 赛诺维信制药公司 | 2020-12-25 | — | — | CN | disclosed |